Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
青防肿痛外敷散治疗膝关节骨关节炎-风湿痹证随机、双盲、安慰剂平行对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical trial of Qingfangzhongtong external application powder in the treatment of knee osteoarthritis-rheumatism syndrome
试验目的是以安慰剂为对照,初步评价青防肿痛外敷散治疗膝关节骨关节炎-风湿痹证的有效性和安全性。 验证青防肿痛外敷散治疗膝关节骨关节炎-症见肿胀、疼痛、屈伸不利的疗效显著优于安慰剂治疗,同时确定青防肿痛外敷散在治疗膝关节骨关节炎风湿痹证方面的任何安全性特征。
[Translation] The purpose of the experiment was to preliminarily evaluate the efficacy and safety of Qingfang Zongtong External Application Powder in the treatment of knee osteoarthritis-rheumatic arthralgia syndrome with placebo as control. It was verified that Qingfang Zhongtong External Application Powder in the treatment of knee osteoarthritis-symptoms with swelling, pain, and unfavorable flexion and extension was significantly better than placebo treatment. any security features.
100 Clinical Results associated with Harbin Yikang Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Harbin Yikang Pharmaceutical Co., Ltd.
100 Deals associated with Harbin Yikang Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Harbin Yikang Pharmaceutical Co., Ltd.